Hugo Diniz, MD 🇵🇹🇪🇺
hugodiniz.medsky.social
Hugo Diniz, MD 🇵🇹🇪🇺
@hugodiniz.medsky.social
"Thoughtfully Create Really Excellent Input"

Interventional Nephrology, ULS São João

#POCUS #VascularAccess #CardioRenal
Thank you for sharing, Cristina!
October 21, 2025 at 11:21 AM
Thank you so much for attending and sharing our session 🤩
Next time, come say hi 👋
June 7, 2025 at 10:16 AM
Yeah. Hopefully the group with HFrEF gets some benefit 🤞
June 6, 2025 at 9:07 PM
Yes @lonniepyne.bsky.social was the presenter! Hopefully he might sneak in to give his thoughts on the matter #ERA25
June 6, 2025 at 6:58 PM
Also, the last author presented a new meta analysis with ACHIEVE and ALCHEMIST. Considering only studies with low risk of bias, still no evidence of positive effect @hswapnil.medsky.social
June 6, 2025 at 5:32 PM
So, about that. @pepasolerr.bsky.social asked about stratification by LVEF/echo data. Looks like only a small % had echo at baseline, but during follow up most patients got one. The author said they are going to look into that #ERA25
June 6, 2025 at 5:30 PM
Sorry, the app might have bugged on me. Are you talking about the Spironolactone trial? This replies are under the sglt2i aki analysis
June 6, 2025 at 3:39 PM
Me neither, but the study was well designed to answer the question. Regarding HF, I don't think so, but they basically used all the Empagliflozin trials for the analysis
June 6, 2025 at 2:58 PM
Prof Anders made a case for the (im)balance between workload (hyperfiltration) and nephron mass as the key interaction

DM is a risk factor - there are no diabetic HF or diabetic cerebral vascular disease. Most cases are probably multifactorial

HTN ckd probably doesnt exist and most are genetic
June 6, 2025 at 2:35 PM
Wasn't aware of that, thanks! Dr. Walsh mentioned it is already accepted for publication in a major journal #ERA25
June 6, 2025 at 10:16 AM
Sibeprenlimab in IgA Nephropathy #ERA25
* Data presented is the 9-month reduction in proteinuria
June 6, 2025 at 9:41 AM
Thanks for letting me know 🙏
June 5, 2025 at 4:08 PM
Reduce the Workload, save your kidneys #ERA25
June 5, 2025 at 3:30 PM
Reposted by Hugo Diniz, MD 🇵🇹🇪🇺
I agree.

Clinically it doesn’t hurt to try a flozin if a patient with diabetes or HF is on an MRA and has hyperkalemia since flozins are clearly indicated in that patient population

But don’t bank on them to fix the issue - it’s a small effect even if true!

#ERA25 #NephSky
June 5, 2025 at 2:58 PM
In a bit more detail... #ERA25
June 5, 2025 at 3:13 PM
Ah, yes. By the way they presented it looked significant. But, still a small decrease is much better than an increased risk 😁
a glass half full of blue liquid on a gray background
ALT: a glass half full of blue liquid on a gray background
media.tenor.com
June 5, 2025 at 10:28 AM
Yes, the lack of morphological and hemodynamic data about the AVGs was also puzzling #ERA25
June 5, 2025 at 10:20 AM